A 4-month, Open-label, Multi-center Study to Explore Tolerability and Safety and Health Outcomes of FTY720 in Patients With Relapsing Forms of Multiple Sclerosis
A 4-month, Open-label, Multi-center Study to Explore Tolerability and Safety and Health Outcomes of FTY720 in Patients With Relapsing Forms of Multiple Sclerosis
This study will assess tolerability and safety and health outcomes in relapsing MS patients taking FTY720.
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria may apply.
Bad Neustadt / Saale, 97616, Germany
S.-Petersburg, 194044, Russia
Essex, RM7 0BE, United Kingdom